Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Sientra stock | $6.96

Learn how to easily invest in Sientra stock.

Sientra, Inc
-$0.27 (-3.38%)

Sientra, Inc is a medical devices business based in the US. Sientra shares (SIEN) are listed on the NASDAQ and all prices are listed in US Dollars. Sientra employs 255 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Sientra

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – SIEN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Sientra stock price (NASDAQ: SIEN)

Use our graph to track the performance of SIEN stocks over time.

Sientra shares at a glance

Information last updated 2021-07-31.
Latest market close$6.96
52-week range$3.21 - $9.14
50-day moving average $7.68
200-day moving average $7.01
Wall St. target price$10.86
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-3.63

Buy Sientra shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, ETFs
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Options, ETFs
$0 per year
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Sientra stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Sientra price performance over time

Historical closes compared with the close of $6.96 from 2021-05-28

1 week (2021-07-24) N/A
1 month (2021-07-02) -12.78%
3 months (2021-05-04) 3.11%
6 months (2021-01-31) N/A
1 year (2020-07-31) N/A
2 years (2019-07-31) N/A
3 years (2018-07-31) N/A
5 years (2016-07-31) N/A

Sientra financials

Revenue TTM $77.5 million
Gross profit TTM $38.9 million
Return on assets TTM -15.71%
Return on equity TTM -553.48%
Profit margin -149.62%
Book value $0.36
Market capitalisation $474.5 million

TTM: trailing 12 months

Shorting Sientra shares

There are currently 11.1 million Sientra shares held short by investors – that's known as Sientra's "short interest". This figure is 10.6% up from 10.1 million last month.

There are a few different ways that this level of interest in shorting Sientra shares can be evaluated.

Sientra's "short interest ratio" (SIR)

Sientra's "short interest ratio" (SIR) is the quantity of Sientra shares currently shorted divided by the average quantity of Sientra shares traded daily (recently around 1.0 million). Sientra's SIR currently stands at 10.9. In other words for every 100,000 Sientra shares traded daily on the market, roughly 10900 shares are currently held short.

However Sientra's short interest can also be evaluated against the total number of Sientra shares, or, against the total number of tradable Sientra shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Sientra's short interest could be expressed as 0.19% of the outstanding shares (for every 100,000 Sientra shares in existence, roughly 190 shares are currently held short) or 0.1962% of the tradable shares (for every 100,000 tradable Sientra shares, roughly 196 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Sientra.

Find out more about how you can short Sientra stock.

Sientra share dividends

We're not expecting Sientra to pay a dividend over the next 12 months.

Sientra share price volatility

Over the last 12 months, Sientra's shares have ranged in value from as little as $3.21 up to $9.14. A popular way to gauge a stock's volatility is its "beta".

SIEN.US volatility(beta: 2.14)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sientra's is 2.1425. This would suggest that Sientra's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Sientra overview

Sientra, Inc. , a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States and internationally. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. It also provides body contouring products; facial and nasal implants; saline filled breast implant sizers; and miraDry System, a non-surgical device for the permanent reduction of underarm sweat, odor, and hair of all colors. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc.

Frequently asked questions

What percentage of Sientra is owned by insiders or institutions?
Currently 3.142% of Sientra shares are held by insiders and 88.271% by institutions.
How many people work for Sientra?
Latest data suggests 255 work at Sientra.
When does the fiscal year end for Sientra?
Sientra's fiscal year ends in December.
Where is Sientra based?
Sientra's address is: 420 South Fairview Avenue, Santa Barbara, CA, United States, 93117
What is Sientra's ISIN number?
Sientra's international securities identification number is: US82621J1051
What is Sientra's CUSIP number?
Sientra's Committee on Uniform Securities Identification Procedures number is: 82621J105

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site